No such message found

...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Japanese publication response from IR
Reply New Message
Back To Forum List View
Japanese publication response from IR
5
Nextblockbuster
Nov 01, 2016 08:32AM
Icon president Re: Japanese publication response from IR
6
BearDownAZ
Nov 01, 2016 02:09PM
Icon president Re: Japanese publication response from IR
1
SanFrancisco99
Nov 01, 2016 03:08PM

Yes, the combo drug trial is a Phase 1 trial.

BearDownAZ

2 Recommendations
Icon president Re: Japanese publication response from IR
3
SanFrancisco99
Nov 01, 2016 04:38PM
Icon president Re: Japanese publication response from IR
3
BearDownAZ
Nov 12, 2016 03:50PM
Icon president Re: Japanese publication response from IR
4
BearDownAZ
Nov 12, 2016 04:10PM
Icon president Re: Japanese publication response from IR
1
SanFrancisco99
Nov 12, 2016 11:13PM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply